Computerized glucose clamp method for the determination of insulin sensitivity in diabetic subjects. 1987

M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta

A new, simplified computerized glucose clamp method was performed for estimation of glucose utilization at the insulin level of postprandial level. The program for the method is based on the mathematical algorithm using values of blood glucose, changes of its concentration and the desired glucose level. The coefficients of variation of the clamped blood glucose values during the last 60 minutes was 6.3 +/- 1.7(%) in normal, 3.7 +/- 0.3(%) in NIDDM, which was within satisfactory limit, and also indicated an attainment of steady state. Glucose infusion curves showed some bumps for the initial 60 min, which did not seriously affect the glucose utilization rate at steady state. In some cases, whose insulin sensitivity was high, CV was not low enough and occasional manual adjustment of K values was required. Average glucose infusion rate was 7.59 +/- 0.85 (mg/kg/min) in normal, and this was significantly lowered in NIDDM (42.3 +/- 3.4) at steady state, indicating a decreased insulin sensitivity for glucose utilization in NIDDM.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003201 Computers Programmable electronic devices designed to accept data, perform prescribed mathematical and logical operations at high speed, and display the results of these operations. Calculators, Programmable,Computer Hardware,Computers, Digital,Hardware, Computer,Calculator, Programmable,Computer,Computer, Digital,Digital Computer,Digital Computers,Programmable Calculator,Programmable Calculators
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
May 2018, Diabetologia,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
March 2007, International journal of obesity (2005),
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
January 2000, Diabetes care,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
December 2006, Nihon rinsho. Japanese journal of clinical medicine,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
April 1983, Clinical endocrinology,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
January 2016, Mymensingh medical journal : MMJ,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
February 1984, Infusionstherapie und klinische Ernahrung,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
November 1977, The Journal of clinical endocrinology and metabolism,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
January 1990, Diabetic medicine : a journal of the British Diabetic Association,
M Harada, and Y Harano, and H Kojima, and M Suzuki, and S Furusawa, and Y Nishino, and T Uchigaki, and H Hyodo, and Y Shigeta
August 1994, Journal of pharmacological and toxicological methods,
Copied contents to your clipboard!